Dan J. Mogren appointed as permanent CEO of Clinical Laserthermia Systems
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announced that the Board of Directors has appointed Dan J. Mogren as permanent CEO of CLS. Dan J. Mogren has been acting CEO since December 1, 2020.– Dan has done an excellent job as acting CEO and demonstrated both leadership skills and a deep understanding of CLS and how to execute on the strategy in order to reach our goals. I am very pleased that Dan will continue as permanent CEO to drive the company forward as we prepare the company for a full market launch, says Hans von Celsing, Chairman of the Board, CLS. –